Allergic Reactions, Anaphylaxis After Moderna COVID-19 Vaccine Allergic Reactions, Anaphylaxis After Moderna COVID-19 Vaccine
This report summarizes the clinical and epidemiologic characteristics of allergic reactions, including anaphylaxis and nonanaphylaxis reactions, after receipt of the Moderna COVID-19 vaccine.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 29, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Anaphylaxis After First Dose of Pfizer COVID-19 Vaccine Anaphylaxis After First Dose of Pfizer COVID-19 Vaccine
This report outlines their clinical and epidemiologic characteristics.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 15, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

European PRAC concludes safety signal of anaphylaxis with COVID-19 Vaccine AstraZeneca, European Medicines Agency
Following a review of the available data, the European PRAC has recommended an update to the product information to include anaphylaxis and hypersensitivity as side effects and to update the existing warning to reflect that cases of anaphylaxis have been reported. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 15, 2021 Category: Consumer Health News Source Type: news

Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
THURSDAY, March 11, 2021 -- Severe reactions consistent with anaphylaxis have occurred among 2.47 per 10,000 health care workers receiving COVID-19 vaccinations, according to a research letter published online March 8 in the Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Real world data reveal risks of allergic reactions after receiving COVID-19 mRNA vaccines
(Massachusetts General Hospital) Among 52,805 health care employees who received mRNA COVID-19 vaccines, 2% experienced allergic reactions, and anaphylaxis occurred at a rate of 2.47 per 10,000 individuals. All vaccine recipients who experienced anaphylaxis recovered without going into anaphylactic shock or requiring a breathing tube. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 9, 2021 Category: Infectious Diseases Source Type: news

Fake vegan meat is dangerous to peanut allergy sufferers: Pea protein could cause fatal anaphylaxis
(Natural News) Vegan meats could bring adverse health effects, most especially to those who are allergic to pea protein. Elana Levine, an allergy specialist in Ontario, Canada, witnessed first-hand the effects of the protein extracts from yellow peas that are used to emulate the texture and taste of animal meat in vegan meat products. It was when... (Source: NaturalNews.com)
Source: NaturalNews.com - March 6, 2021 Category: Consumer Health News Source Type: news

First anaphylaxis case from a deodorant spray including lysozyme chloride - Muramatsu R, Saga M, Muramatsu K.
[The publisher has not provided an abstract for this article.] Language: en... (Source: SafetyLit)
Source: SafetyLit - March 4, 2021 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Covid vaccine side effects: Anaphylaxis is a rare but life-threatening reaction
CORONAVIRUS vaccines are hastening the end of the pandemic, with hospital ICU rates plummeting. Most people getting the Pfizer/BioNTech vaccine will experience mild side effects at most. In very rare instances, anaphylaxis may occur - what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - March 2, 2021 Category: Consumer Health News Source Type: news

Covid vaccine side effects: Anaphylaxis is a rare but severe allergic reaction
CORONAVIRUS vaccines are hastening the end of the pandemic, with hospital ICU rates plummeting. Most people getting the Pfizer/BioNTech vaccine will experience mild side effects at most. In very rare instances, anaphylaxis may occur - what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - March 2, 2021 Category: Consumer Health News Source Type: news

1998 to 2018 Saw Jump in Admissions for Food-Induced Anaphylaxis
THURSDAY, Feb. 18, 2021 -- From 1998 to 2018, there was an increase in hospital admissions for food-induced anaphylaxis in the United Kingdom, according to a study published online Feb. 17 in The BMJ. Alessia Baseggio Conrado, Ph.D., from Imperial... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 18, 2021 Category: Pharmaceuticals Source Type: news

Hospitalizations for Food Anaphylaxis Triple, but Deaths Down Hospitalizations for Food Anaphylaxis Triple, but Deaths Down
Cow's milk is the leading cause of fatal anaphylaxis among children, new data show.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 18, 2021 Category: Emergency Medicine Tags: Allergy & Clinical Immunology News Source Type: news

No provision of insurance for recipients of COVID-19 vaccine: Ashwini Choubey, MoS for Health
Measures have been put in place like availability of anaphylaxis kits at each vaccination site, immediate referral to AEFI management centre and observation of vaccine recipients for 30 minutes at session site for any adverse events so as to ensure timely corrective measure, Choubey said in a written reply. (Source: The Economic Times)
Source: The Economic Times - February 9, 2021 Category: Consumer Health News Source Type: news

Pfizer withdraws vaccine plea as panel seeks India trial data
The panel observed that incidents of serious adverse effects such as palsy and anaphylaxis and the causality of the events with the vaccine were being investigated in some of the countries where these jabs have been administered. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 5, 2021 Category: Pharmaceuticals Source Type: news

COVID Vaccine Anaphylaxis: Who Is at Risk? COVID Vaccine Anaphylaxis: Who Is at Risk?
What's the most likely cause of the reported anaphylactic reactions to the COVID vaccines, and how can physicians keep patients safe?Medscape Allergy & Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology Viewpoint Source Type: news

COVID-19 vaccination programme, RCGP (updated 28th January 2021)
The latest updates on the COVID-19 vaccine, including: COVID-19 Vaccination FAQs SARS-CoV-2 Vaccination #RCGPLive: COVID-19 vaccination in general practice Clinician FAQs and guidance on COVID-19 vaccine for patients receiving Systemic Anti-Cancer Therapy (SACT) Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 29, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe CO...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, wit...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021
This report describes cases of anaphylaxis after administration of first doses of the Moderna COVID-19 vaccine during December 21, 2020-January 10, 2021. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 28, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Vaccination Vaccine Adverse Event Reporting System (VAERS) Vaccines COVID-19 Coronavirus Disease 2019 Source Type: news

The First 15 Minutes: Anaphylaxis After COVID Vaccination The First 15 Minutes: Anaphylaxis After COVID Vaccination
Most postvaccination symptoms are expected and not serious, although clinicians should be ready to manage the rare case of anaphylaxis.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2021 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

The First 30 Minutes: Anaphylaxis After COVID Vaccination The First 30 Minutes: Anaphylaxis After COVID Vaccination
Most postvaccination symptoms are expected and not serious, although clinicians should be ready to manage the rare case of anaphylaxis.Medscape Internal Medicine (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - January 27, 2021 Category: Emergency Medicine Tags: Internal Medicine Commentary Source Type: news

Moderna's and Pfizer's vaccines share the same problem: They're unsafe for people with allergies
(Natural News) A physician at the Boston Medical Center (BMC) suffered an allergic reaction after receiving the much-talked about Moderna vaccine. The incident, which occurred on Dec. 24, involved Dr. Hossein Sadrzadeh, a geriatric oncologist with a severe allergy to shellfish. Sadrzadeh reported symptoms of anaphylaxis similar to what he experiences with shellfish almost immediately after receiving the Moderna... (Source: NaturalNews.com)
Source: NaturalNews.com - January 26, 2021 Category: Consumer Health News Source Type: news

2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots
MONDAY, Jan. 25, 2021 -- The rate of anaphylaxis is 2.5 cases per million Moderna COVID-19 vaccine doses administered as of Jan. 10, 2021, according to research published in the Jan. 22 issue of the U.S. Centers for Disease Control and Prevention... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Moderna Covid-19 Vaccine: Here Is The Risk Of Severe Allergic Reactions
A new CDC reported listed the rate of anaphylaxis after the Moderna Covid-19 mRNA as slightly lower than that of the Pfizer/BioNTech vaccine. But is this difference real? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 23, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Covid US: 10 out of 4m who got Moderna vaccine suffered anaphylaxis
Just one person who went into anaphylactic shock - a life-threatening response in which a person's airways can become too narrow for them to breathe - had no history of allergies, CDC reports. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2021 Category: Consumer Health News Source Type: news

10 out of 4 million Americans to get Moderna's vaccine suffered anaphylaxis
Just one person who went into anaphylactic shock - a life-threatening response in which a person's airways can become too narrow for them to breathe - had no history of allergies, CDC reports. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2021 Category: Consumer Health News Source Type: news

Allergic reactions including anaphylaxis after receipt of 1st dose of Pfizer-BioNTech COVID-19 Vaccine
(JAMA Network) This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the Centers for Disease Control and Prevention in the first week of use of the Pfizer-BioNTech COVID-19 vaccine in the United States. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 21, 2021 Category: International Medicine & Public Health Source Type: news

How Safe Are Covid-19 Coronavirus Vaccines? Here ’s The Allergic Reaction Risk
A CDC report indicated that there were 21 cases of anaphylaxis (severe allergic reactions) out of 1,893,360 people who had received first doses of the Pfizer-BioNTech Covid-19 vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

COVID-19 vaccination programme, RCGP (updated 14th January 2021)
The latest updates on the COVID-19 vaccine, including: COVID-19 Vaccination FAQs SARS-CoV-2 Vaccination #RCGPLive: COVID-19 vaccination in general practice Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 15, 2021 Category: Consumer Health News Source Type: news

In lab study, nanoparticle shows promising results for treating severe allergies
For about 1 in 13 children in the U.S., usually harmless foodstuffs such as milk, eggs and peanuts can send the body ’s natural defenses into overdrive.Symptoms of food allergies can vary widely, but at worst, a systemwide allergic response can lead to anaphylaxis, a life-threatening condition characterized by a sudden drop in blood pressure and difficulty breathing.Although there are now some preventive measures for food-induced anaphylaxis, there are not yet any long-lasting solutions — treatments capable of locking the immune system into a state of tolerance, so that it doesn’t respond to allergens.Now...
Source: UCLA Newsroom: Health Sciences - January 14, 2021 Category: Universities & Medical Training Source Type: news

Update on COVID-19 pandemic, BMJ Best Practice (updated 8th January 2021)
Over 88 million cases have been reported globally, with over 49 million cases recovered so far, and approximately 1.9 million deaths according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. What's new at this update: Epidemiology: updated data on children and pregnant women; updated risk factors (residence in a long-term care facility; cardiovascular diseases; diabetes; chronic respiratory diseases). Aetiology: new section on SARS-CoV-2 variants; updated data on secondary attack rates. Investigations: WHO recommends PCR test results are considered in combinatio...
Source: Current Awareness Service for Health (CASH) - January 11, 2021 Category: Consumer Health News Source Type: news

Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine United States, December 14-23, 2020, Morbidity and Mortality Weekly Report
During 14 –23 Dec 2020, there were 21 reports of anaphylaxis after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million doses) made to the Vaccine Adverse Event Reporting System; 71% occurred within 15 minutes of vaccination. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2021 Category: Consumer Health News Source Type: news

What Are the Signs of Anaphylaxis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 11, 2021 Category: General Medicine Source Type: news

What Are the Two Signs of Anaphylaxis?
Title: What Are the Two Signs of Anaphylaxis?Category: Diseases and ConditionsCreated: 1/11/2021 12:00:00 AMLast Editorial Review: 1/11/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - January 11, 2021 Category: Allergy & Immunology Source Type: news

11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
THURSDAY, Jan. 7, 2021 -- As of Dec. 23, 2020, researchers determined there were 21 cases of anaphylaxis (11.1 per million doses administered) after receipt of the first dose of the Pfizer-BioNTech COVID-19 vaccine in the United States, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 7, 2021 Category: Pharmaceuticals Source Type: news

Severe Allergic Reactions to COVID-19 Vaccine Are Rare: CDC
The majority of people experiencing anaphylaxis had a history of allergic reactions, a report by the agency finds. (Source: The Scientist)
Source: The Scientist - January 7, 2021 Category: Science Tags: News & Opinion Source Type: news

What You Need to Know About the Coronavirus Outbreak
That ’s a rate of 11.1 cases of anaphylaxis per 1 million recipients. ... Seventeen of the 21 who experienced anaphylaxis had a history of similar reactions to other vaccines or medications, the CDC... (Source: AARP.org News)
Source: AARP.org News - January 7, 2021 Category: American Health Source Type: news

What to Know About Allergic Reactions to COVID Vaccines
There have been a handful of anaphylaxis cases; be aware if you are at risk ... En espa ñol | Among 1.8 million people in the U.S. who've received the first dose of Pfizer-BioNTech or Moderna COVID-... (Source: AARP.org News)
Source: AARP.org News - January 7, 2021 Category: American Health Source Type: news

Anaphylaxis Cases After COVID Vaccine Rising But Still Rare: CDC Anaphylaxis Cases After COVID Vaccine Rising But Still Rare: CDC
With 29 confirmed cases of anaphylaxis following COVID-19 vaccine administration, clinicians should be prepared to treat this side effect, CDC's Messonnier said. But cases remain rare.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - January 6, 2021 Category: Emergency Medicine Tags: Allergy & Clinical Immunology News Source Type: news

Allergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDC
WEDNESDAY, Jan. 6, 2021 -- Cases of anaphylactic shock caused by COVID-19 vaccines are very rare, based on numbers from the first week and a half of vaccinations in the United States, federal public health officials said Wednesday. There have been... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 6, 2021 Category: General Medicine Source Type: news

At least 21 Americans had life-threatening anaphylaxis after receiving Pfizer's vaccine, CDC reveals
A new CDC report revealed 21 people out of 1.9 million suffered anaphylaxis after getting the first dose of Pfizer-BioNTech's coronavirus vaccine between December 14 and 23. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2021 Category: Consumer Health News Source Type: news

Essential guidance, RCGP (updated 6th January 2021)
This guidance provides key information for GPs during the COVID-19 outbreak and includes, amongst other things, sections on: Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine SARS-CoV-2 Vaccination. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 6, 2021 Category: Consumer Health News Source Type: news

Patients with history of anaphylaxis can have Pfizer COVID jab, says MHRA
Patients with a history of severe allergy are now able to have the Pfizer/BioNTech COVID-19 vaccine, the MHRA has said. (Source: GP Online News)
Source: GP Online News - January 6, 2021 Category: Primary Care Tags: Coronavirus Source Type: news

Maintaining Safety with SARS-CoV-2 Vaccines, New England Journal of Medicine
Viewpoint article comments on the expedited recent approval of these vaccines and reports of anaphylaxis with the Pfizer vaccine and concludes careful vaccine-safety surveillance over time will be needed to inform a strategic and systematic approach to vaccine safety. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 5, 2021 Category: Consumer Health News Source Type: news

Too Many Americans Still Mistrust the COVID-19 Vaccines. Here ’s Why
If you’re feeling impatient waiting your turn for a COVID-19 vaccine, here’s a little good news: Angela Padgett will gladly give you her place in line—at least for now. Padgett, president of a day spa in Raleigh, N.C., is under no illusions about the mortal danger the pandemic poses to herself, her family and the world writ large—indeed, she had COVID-19 back in July. But as for the vaccine that is supposed to put an end to all of the suffering at last? Not today. “I am a little bit hesitant,” she says. “I can appreciate President Trump trying to get this moving fast and I’ve...
Source: TIME: Health - January 5, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Source Type: news

Essential guidance, RCGP (updated 30th December 2020)
This guidance provides key information for GPs during the COVID-19 outbreak and includes, amongst other things, sections on: Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine SARS-CoV-2 Vaccination. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 4, 2021 Category: Consumer Health News Source Type: news

Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
(Massachusetts General Hospital) Reports of possible allergic reactions to COVID-19 vaccines have raised public concern; however, allergists note that allergic reactions to vaccines are rare, and COVID-19 vaccine allergic reactions will have a similarly low rate of occurrence. Individuals with a history of anaphylaxis to an injectable drug or vaccine containing polyethylene glycol or polysorbate should speak with an allergist before getting vaccinated, but patients with severe allergies to foods, oral drugs, latex or venom can safely receive the COVID-19 vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 31, 2020 Category: International Medicine & Public Health Source Type: news

How Drive-Through COVID-19 Vaccine Clinics Could Help Inoculate the U.S.
Even though the COVID-19 vaccine clinic wasn’t due to open until 5 p.m., cars started lining up around about 15 minutes early, just as darkness, and some snowflakes, started to fall. The vehicles, some ambulances and other types of emergency response cars, belonged to 70 first responders in Minnesota’s Carlton County who wanted to be among the first in the area to get vaccinated against COVID-19. They drove through the large parking garage in Carlton, run by the county’s transportation department, where they received one of the northern Minnesota county’s allotment of 100 doses of the vaccine made b...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine. (Source: NYT Health)
Source: NYT Health - December 25, 2020 Category: Consumer Health News Authors: Katherine J. Wu Tags: Vaccination and Immunization Drugs (Pharmaceuticals) Anaphylactic Shock Coronavirus (2019-nCoV) Immune System Allergies Centers for Disease Control and Prevention Moderna Inc Pfizer Inc your-feed-healthcare Source Type: news

NIH Is Planning A Study To Find Out What ’s Causing Allergic Reactions To Pfizer’s Covid-19 Vaccine
The CDC is investigating six cases of anaphylaxis from the vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 21, 2020 Category: Pharmaceuticals Authors: Rachel Sandler, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news